What is MaxCyte's total liabilities?

MaxCyte (MXCT) reported total liabilities of $26.59M in Q1 2026.

How has MaxCyte's total liabilities changed year-over-year?

MaxCyte's total liabilities decreased by 13.0% year-over-year, from $30.55M to $26.59M.

What is the long-term trend for MaxCyte's total liabilities?

Over 5 years (2020 to 2025), MaxCyte's total liabilities has grown at a 10.8% compound annual growth rate (CAGR), from $18.55M to $31.02M.

What does total liabilities mean?

The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.

MaxCyte MXCT Total Liabilities

Total Liabilities at other companies

Bio-Rad LaboratoriesBIO

$2.94B+3.2%

Ginkgo BioworksDNA

$5.69M-34.0%

Immix Biopharma, Inc.IMMX

$11.45M+11.2%

Rapid Micro BiosystemsRPID

$41.97M+110%

PDE

Pro-Dex, Inc.PDEX

$29.78M+2.7%

Thermo Fisher ScientificTMO

——

Other financials

Income statement

See full

Revenue$9.7M-7.1%

Gross profit$8.1M-9.1%

Operating income-$6.2M+49.7%

Net income-$4.8M+53.7%

EPS (diluted)-$0.04+60.0%

Balance sheet

See full

Cash & equivalents$14.6M-37.8%

Total debt$17.5M-7.1%

Total equity$167.9M-15.8%

Total assets$194.5M-15.4%

Cash flow

See full

Operating cash flow-$8.2M+43.3%

CapEx$72.0K-89.0%

Free cash flow-$8.2M+45.3%

Valuation

See full

Market cap$130.15M-46.8%

Enterprise value$133.08M-46.3%

P/S4×-2.8×

Profitability

See full

Gross margin80.5%-0.4pp

Operating margin-141.8%+6.4pp

Net margin-121.2%+12.3pp

FCF margin-90.9%+3.7pp

Returns & leverage

See full

Return on equity-21.3%+2.0pp

Debt / equity0.1×0.0×

Current ratio12×-0.2×

Where this comes from

Reported directly by MaxCyte in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MaxCyte's total liabilities?: MaxCyte (MXCT) reported total liabilities of $26.59M in Q1 2026.
How has MaxCyte's total liabilities changed year-over-year?: MaxCyte's total liabilities decreased by 13.0% year-over-year, from $30.55M to $26.59M.
What is the long-term trend for MaxCyte's total liabilities?: Over 5 years (2020 to 2025), MaxCyte's total liabilities has grown at a 10.8% compound annual growth rate (CAGR), from $18.55M to $31.02M.
What does total liabilities mean?: The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.